Compare BioNTech SE - ADR (BNTX) vs Fabrinet (FN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Fabrinet — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Fabrinet trades at $555 (market cap $18.84B). The key difference: BioNTech SE - ADR is the larger of the two by market cap, and Fabrinet is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | FN | |
|---|---|---|
Market Cap | $23.31B | $18.84B |
Sector | Health | Technology |
52-Week High | $119.34 | $746.47 |
52-Week Low | $83.89 | $277.04 |
Enterprise Value | $6.60B | $17.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Fabrinet
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →
